🔬🌟 Attending the EASL SLD Summit has been eye-opening! Day 2 was filled with incredible scientific highlights that pushed the boundaries of knowledge in the field of MASH research. Let me share some of the exciting sessions I attended:

In the Plenary session, we explored the mysteries of MASH research, delving into the complexities of human and rodent metabolism and uncovering challenges in translating pre-clinical data to successful trials. It was a fascinating journey!

The session on 'Sexual Dimorphism and Circadian Clock: New Insights' opened a new frontier, discussing MASLD/MASH complexities, sexual dimorphism, and the impact of the circadian clock on research and practice. The discussions bridged gaps and advanced our understanding.

The State-of-the-Art Session on cardiovascular disease in MASLD clinical care and trials raised intriguing questions on the liver's role in a multisystem disease, particularly its connection to cardiovascular events. Exciting treatment pathways were unveiled.

The captivating Plenary session on the link between MASLD, dyslipidaemia, and diabetes highlighted the bidirectional impact of these conditions, opening new avenues for treatment strategies.

In the Special Techniques session, breakthroughs in single-cell multi-omics technology were unveiled, providing insights into liver cell diversity and spatial dynamics in MAFLD progression. Cutting-edge techniques are truly shaping the future of research.

Lastly, the State-of-the-Art Session on liver organoids showcased the evolving role of these in vitro models in bridging the gap between animal research and drug development. The future looks promising!

✨ Can't wait to share more from the EASL SLD Summit! Stay tuned for further updates. #EASL #SLDSummit #MASHResearch #ScientificHighlights #CuttingEdgeTech #LiverOrganoids #RevolutionaryResearch